Clinical trial CA209-8RX
A national, prospective, Therapeutic Non-Interventional Clinical Trial (TNICT) in patients receiving adjuvant nivolumab therapy for resected melanoma
| Cancers | |
|---|---|
| Organ | Skin |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Prospective observational study
|
| Phase | Trial phase 4 |
| Academic trial | Non |
| Sponsor | BMS - Bristol Myers Squibb int. |
| BECT Identifier | B143201837780 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03771859 |
| Inclusion criteria | Complete resection |
| Last update |